[PRESS RELEASE] – EDMONTON, Alberta, Feb. 6, 2025 – Aurora Cannabis Inc., a leading global medical cannabis company based in Canada, announced a strategic supply agreement (the "agreement") with SNDL Inc., a Canadian licensed producer and vertically integrated cannabis enterprise.
Under this agreement, SNDL is expected to supply Aurora with premium cannabis flower product grown at SNDL's indoor facility in Atholville, New Brunswick. The term of the agreement is for three years with an option to extend and an estimated value of $27 million. Aurora and SNDL have an existing and successful supply relationship for the manufacturing of various cannabis products and input material.
"Following our strong third-quarter performance driven by record-setting growth in our international medical cannabis segment, Aurora remains focused on a balanced approach to operating a hybrid manufacturing network of in-house and third-party cultivation. We value our relationship with SNDL and their shared commitment to cultivation excellence," Aurora Cannabis Executive Chairman and CEO Miguel Martin said.
"As Canada's leading integrated cannabis company, SNDL is well-positioned as a supplier of quality cannabis products to commercial partners like Aurora. We have a shared approach to quality and cultivation excellence and look forward to expanding this relationship further," SNDL CEO Zach George said.
